Triple-Boarded Neurologist | Stroke/TBI/Hemorrhage

Specialties & Experience of this Expert Witness

Additional Information

Dr. Kulik is a triple board-certified neurologist subspecialty trained in Vascular Neurology and Neurocritical Care, with more than fourteen years of clinical experience in tertiary stroke centers and neurointensive care units. He practices as a staff neurologist at Saint Luke's Marion Bloch Neuroscience Institute in Kansas City, a Comprehensive Stroke Center and Level I Trauma Center, and is a Clinical Associate Professor of Neurology at the University of Missouri–Kansas City. He completed neurology residency and chief residency at the University of Rochester and fellowships in Vascular Neurology and Neurocritical Care at the Washington University Consortium in Saint Louis. He is licensed in more than twenty states and accepts retentions from plaintiff and defense counsel nationwide. His clinical and medico-legal work centers on acute ischemic stroke and large-vessel occlusion, intracerebral and subarachnoid hemorrhage, traumatic brain injury and concussion, hypoxic-ischemic brain injury and post-cardiac arrest neuroprognostication, neurocritical care, disorders of consciousness, brain death determination, and acute immune-mediated neurological disease including Guillain-Barré syndrome. He is a Certified Independent Medical Examiner (ABIME) and applies the AMA Guides to the Evaluation of Permanent Impairment, 5th and 6th editions, in impairment ratings. He is also a Credentialed ImPACT Consultant (CIC) and a Certified Professional in Patient Safety (CPPS), with prior service as Section Chief for Stroke and Neurocritical Care, Medical Director of a NeuroICU, and Director of Quality at a major academic health system. Dr. Kulik has served as Site Principal Investigator and Co-Principal Investigator on more than a dozen multicenter clinical trials in stroke and neurocritical care, including the NIH/NINDS-sponsored SATURN, Sleep SMART, MOST, and CHARM trials, and as a co-investigator on the POINT (NEJM, 2018) and ARCADIA studies. He is senior author of the INTREPID randomized trial of fever prevention in acute vascular brain injury (JAMA, 2024) and has authored more than thirty peer-reviewed publications and book chapters on intracerebral hemorrhage, subarachnoid hemorrhage, neurocritical care prognostication, and stroke systems of care. He has contributed to national guideline-writing committees for the American Heart Association and the American Academy of Neurology, and is a member of the American College of Legal Medicine. Through CorteXion LLC, Dr. Kulik provides medico-legal consultation on standard of care, causation, and impairment in cases involving acute neurological emergencies, brain and spine injury, and long-term neurologic outcomes. His reports aim to give attorneys the medicine before the opinion: a careful reconstruction of the record, a transparent application of the relevant standard, and a position that holds up in deposition. He publishes The CorteXion Briefs, a periodical of short essays on neurological evidence in litigation, at briefs.cortexion.co.